Search Results 311-320 of 829 for ai官网旗舰店,ai创作网,网络智能ai,ai工具合集官网,ai生成效果图网站,等欢迎访问豌豆Ai站群搜索引擎系统官方网站:www.wd.chat

  1. A Study of NGM282 When Given to Subjects with Functional Constipation and to Healthy Individuals - Mayo Clinic

    The purpose of this study is to determine the effect of NGM282 on colonic transit, bile acid homeostasis, and fecal fat in subjects with functional constipation ...

  2. RBX2660 Administered by Colonoscopy for Recurrent Clostridioides difficile Infection - Mayo Clinic

    The purpose of this study is to explore the safety of RBX2660 when delivered by colonoscopy in subjects with recurrent Clostridioides difficile infection (rCDI) ...

  3. A Phase 1 Study Evaluating the Safety, PK, and Clinical Effects of PT-112 in Subjects With Advanced Solid Tumors

    Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and ...

  4. Anorectal Pressures and Simultaneous Dynamic Imaging - Mayo Clinic

    About this study. Many people have constipation because they cannot defecate. However, we do not fully understand the mechanisms of normal defecation or ...

  5. Blinatumomab and Combination Chemotherapy or Dasatinib, Prednisone, and Blinatumomab in Treating Older Patients With Acute Lymphoblastic Leukemia - Mayo Clinic

    The purpose of this study is to test any good and bad effects of adding the drug Blinatumomab to different doses of standard combination of chemotherapy drugs.

  6. Liewei Wang, M.D., Ph.D. - Mayo Clinic Faculty Profiles

    D., is focused on pharmacogenomics, a critical component of individualized medicine that studies the role of inheritance in variation in drug response. Patients ...

  7. Wei Liu, Ph.D. - Mayo Clinic Faculty Profiles

    Mayo Clinic researcher Wei Liu, Ph.D., focuses on radiotherapy and the best way to improve patient outcomes.

  8. Study of Single Agent CJM112, and PDR001 in Combination With LCL161 or CJM112 in Patients With Multiple Myeloma - Mayo Clinic

    Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and ...

  9. Publications - Xiaoying Liang, Ph.D. - Mayo Clinic

    Liu C, Beltran CJ, Shen J, Zhang N, Pi Y, Bues M, Park J, Lu B, Yaddanapudi S, Tan J, Furutani KM, Liang X. Worst-Case Robustness Evaluation Methods for ...

  10. Dose Escalation Study Investigating the Safety, Tolerability, Pharmacokinetics, Pharmacodynamics of ASP2215 in Patients With Relapsed or Refractory Acute Myeloid Leukemia - Mayo Clinic

    The objective of this study is to assess the safety and tolerability, including the maximum tolerated dose, of ASP2215 in subjects with relapsed or treatment- ...